Investor Relations
Access Transformative Deal Flow
NAZR Ventures provides institutional investors, family offices, multi-family offices, and sovereign funds with curated access to high-conviction healthcare and frontier technology ventures — at the formation stage, before they reach the broader market.
Why Partner With NAZR Ventures
Proprietary Access. Institutional Rigour.
We sit at the intersection of clinical expertise, venture creation, and global capital networks. Our deal flow is sourced directly from founders, research institutions, and healthcare systems — not intermediaries. Every opportunity we bring to capital partners has been validated through our own strategic and clinical lens before it reaches you.
Proprietary Deal Flow
Direct access to ventures sourced through our global network of founders, hospitals, research institutions, and healthcare systems — not available through traditional channels.
Clinical & Strategic Validation
Every venture is assessed through a rigorous clinical, commercial, and strategic lens before being presented to capital partners. We invest our own time and expertise before we ask you to invest capital.
Co-Creation Model
We don't just introduce deals — we build them. Our capital partners benefit from our active involvement in venture formation, governance, and execution throughout the lifecycle.
Global Execution Capability
With relationships spanning the GCC, Europe, North America, Asia-Pacific, and Africa, we facilitate cross-border transactions and market entry strategies that create real enterprise value.
Aligned Incentives
Our model is built on long-term partnership, not transaction fees. We are aligned with our capital partners at every stage — from first investment through to exit.
Sector Depth
Deep domain expertise across oncology, precision medicine, frontier technologies, and sustainable infrastructure — the sectors where we believe the most significant value creation opportunities exist.
Who We Work With
Built for Institutional Capital
Family Offices
Single and multi-family offices seeking direct co-investment opportunities in healthcare and frontier technology ventures with strong risk-adjusted return profiles.
Multi-Family Offices
MFOs looking to provide their clients with curated access to institutional-quality venture opportunities across healthcare, life sciences, and deep technology.
Sovereign Wealth Funds
Sovereign entities and government-linked investment vehicles seeking strategic exposure to transformative healthcare infrastructure and frontier innovation.
Institutional Investors
Endowments, pension funds, and institutional asset managers building allocations to healthcare venture and private equity with a global mandate.
Strategic Corporate Investors
Healthcare systems, pharmaceutical groups, and technology companies seeking strategic investment and partnership opportunities aligned with their innovation agenda.
Impact & ESG Investors
Capital partners with a mandate to invest in ventures that deliver measurable health, social, and environmental impact alongside financial returns.
Current Pipeline
Open Investment Opportunities
The following funds and ventures are currently open to qualified investors. Each represents a distinct entry point into our portfolio — from dedicated sector funds to direct venture co-investment.
Health Innovation Fund
FundHealthcare & Life SciencesA dedicated fund backing transformative healthcare ventures across diagnostics, therapeutics, digital health, and life sciences. Open to institutional investors and family offices.
Advanced Oncology & Healthcare Infrastructure Fund
FundOncology • Healthcare InfrastructureA global investment fund targeting the full spectrum of advanced oncology — precision diagnostics, next-generation therapeutics, immunotherapy platforms, and the clinical infrastructure required to deliver them at scale across multiple continents. Open to qualified institutional investors, family offices, and sovereign capital partners seeking high-conviction exposure to one of the world's fastest-growing and most critical healthcare sectors.
Autonomous Robotic Surgery System
Direct Co-InvestmentFrontier TechnologiesA next-generation autonomous robotic surgery system and its proprietary AI brain. Total addressable raise of $250M. Targeting global hospital systems and surgical centres.
Preventive Health Ecosystem
Direct Co-InvestmentHuman Performance & LongevityA cloud-enabled platform delivering personalised preventive care globally. Currently in active growth-stage deployment across international markets.
How It Works
A Structured Path to Partnership
Initial Conversation
We begin with a confidential conversation to understand your investment mandate, sector preferences, and return objectives.
Curated Deal Flow
Based on your mandate, we provide curated access to relevant opportunities from our current pipeline — with full supporting materials.
Due Diligence Support
We provide comprehensive support throughout your due diligence process — clinical, commercial, and financial — drawing on our deep domain expertise.
Structuring & Execution
We work alongside your team and legal advisors to structure the investment and execute the transaction efficiently.
Ongoing Partnership
Post-investment, we remain actively involved in the ventures we back — providing governance support, strategic guidance, and ongoing reporting.
Get In Touch
Explore Our Pipeline
Complete the form below and a member of our team will be in touch to arrange a confidential conversation about our current deal flow and investment opportunities.